Boston Lighthouse Innovations

Boston Lighthouse Innovations (BLI) drives precision medicine forward by empowering pathology laboratories and healthcare systems with cutting-edge, scalable genomic software and analytics solutions. Interested in a Demo? Email us at sales@bostonlighthouse.us Founded on technology developed at Massachusetts General Hospital’s Center for Integrated Diagnostics, BLI specializes in operationalizing comprehensive genomic profiling (CGP) workflows to transform complex genomic data into actionable clinical insights. Our BioBeam Platform integrates into existing laboratory infrastructure, providing a full-spectrum solution, from sample accessioning to clinical variant interpretation, sign-out, and reporting. Key highlights of the BioBeam Platform-Scalable Bioinformatics Pipelines: Automates high-throughput variant detection, reducing manual intervention and accelerating turnaround times-Advanced Clinical Reporting: Generates fully customizable, intuitive reports that integrate genomic findings directly into clinical workflows-Cloud-based Data Management & Analytics: Ensures secure, centralized access to genomic data, enabling real-time insights, predictive analytics, and continuous quality improvement to your data. By leveraging AI-driven variant prioritization and a robust clinical decision-support framework, BLI enables labs to efficiently identify actionable biomarkers, improving treatable variant detection rates by up to 40%. Our proven track record includes strategic partnerships with global oncology leaders such as Oncoclínicas and other major academic medical centers, bolstering precision medicine initiatives worldwide. BLI is committed to making precision medicine scalable and clinically integrated, driving improved patient outcomes worldwide.